Johnson & Johnson (J&J) has submitted an application for the COVID-19 vaccine. The single dose is now an emergency with the US Food and Drug Administration (FDA) and is
slotxo preparing to submit its approval to the relevant European authorities over the coming weeks.
J&J filed for FDA approval after the company reported on Jan. 29 that J&J vaccine was 66% effective against COVID-19 in trials worldwide.
“When I got permission to use the COVID-19 vaccine. Can be an emergency We will then be able to deliver the vaccine, ”said J&J Chief Scientist Dr. Paul Stoffels in a statement.
After the company has submitted an approval for the vaccine It will take time for agencies involved to analyze the data. And the advisory committee must come to meet and discuss
A single dose of J & J's vaccine is expected to enhance the efficacy of the US COVID-19 vaccine program amid concerns from the coronavirus infection. More and more mutants found in England.